NCT05366127View on ClinicalTrials.gov

Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

July 30, 2026

Study Completion Date

July 30, 2026

Conditions
Bullous Pemphigoid
Interventions
OTHER

IGA score

IGA score will be assessed by 2 blinded investigators

OTHER

BULLOUS PEMPHIGOID DISEASE AREA INDEX (BPDAI)

BPDAI will be assessed by 2 by 2 blinded investigators

Trial Locations (11)

Unknown

Bordeaux University Hospital, Bordeaux

Dijon University Hospital, Dijon

Lille University Hospital, Lille

Lyon University Hospital, Lyon

Montpellier University Hospital, Montpellier

Nantes University Hospital, Nantes

Avicennes Hospital, Paris

Bichat Hospital, Paris

Henri Mondor Hospital, Paris

Saint-Louis Hospital, Paris

Reims University Hospital, Reims

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT05366127 - Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid | Biotech Hunter | Biotech Hunter